roche glp 1 drug obesity helps patients shed 22.7% of weight in mid-stage trial Roche, trailing in obesity, showcases

From a 30 mg vial, that means at most 2.5 mL of diluent

As my condition has been so up and down over the years it just gets really complicated, and I can barely explain it to myself let alone someone else

GLP-1 agonists to treat the heart, the kidneys and the brain

KomlosiKHavasiVBeneJSuleNPajorLNicolaiRet alHistopathologic abnormalities of the lymphoreticular tissues in organic cation transporter 2 deficiency: evidence for impaired B cell maturation

ICYMI: Cell and Gene Therapy in Medicaid We are living at the leading edge of cell and gene therapies (CGT) rapidly proliferating in the health care system including some one-time, durable treatments for rare and severe genetic conditions like cancers and sickle cell disease (SCD)